Clinical trial
Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
NCT00415376 · Northwestern University, Other · Withdrawn
Key facts
| NCT number | NCT00415376 |
|---|---|
| Title | Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases |
| Official title | A Pilot Study of the Efficacy of Levetiracetam in Patients With Seizures From Brain Metastases |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Seizure, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | levetiracetam, quality-of-life assessment |
| Enrollment | 0 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Dec 22, 2006 |
| Last update posted | May 18, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: